Abstract:: Human embryonic stem cells (hESCs) have an enormous potential as a source for cell replacement therapies, tissue engineering, and in vitro toxicology applications. The lack of standardized and robust bioprocesses for hESC expansion has hindered the application of hESCs and their derivatives in clinical settings. We developed a robust and well-characterized bioprocess for hESC expansion under fully defined conditions and explored the potential of transcriptomic and metabolomic tools for a more comprehensive assessment of culture system impact on cell proliferation, metabolism, and phenotype. Two different hESC lines (feeder-dependent and feeder-free lines) were efficiently expanded on xeno-free microcarriers in stirred culture systems. Both hESC lines maintained the expression of stemness markers such as Oct-4, Nanog, SSEA-4, and TRA1-60 and the ability to spontaneously differentiate into the three germ layers. Whole-genome transcriptome profiling revealed a phenotypic convergence between both hESC lines along the expansion process in stirred-tank bioreactor cultures, providing strong evidence of the robustness of the cultivation process to homogenize cellular phenotype. Under low-oxygen tension, results showed metabolic rearrangement with upregulation of the glycolytic machinery favoring an anaerobic glycolysis Warburg-effect-like phenotype, with no evidence of hypoxic stress response, in contrast to two-dimensional culture. Overall, we report a standardized expansion bioprocess that can guarantee maximal product quality. Furthermore, the "omics" tools used provided relevant findings on the physiological and metabolic changes during hESC expansion in environmentally controlled stirred-tank bioreactors, which can contribute to improved scale-up production systems. Significance: The clinical application of human pluripotent stem cells (hPSCs) has been hindered by the lack of robust protocols able to sustain production of high cell numbers, as required for regenerative medicine. In this study, a strategy was developed for the expansion of human embryonic stem cells in well-defined culture conditions using microcarrier technology and stirred-tank bioreactors. The use of transcriptomic and metabolic tools allowed detailed characterization of the cell-based product and showed a phenotypic convergence between both hESC lines along the expansion process. This study provided valuable insights into the metabolic hallmarks of hPSC expansion and new information to guide bioprocess design and media optimization for the production of cells with higher quantity and improved quality, which are requisite for translation to the clinic.

Long Term Expansion of Undifferentiated Human Ips and ES Cells in Suspension Culture Using a Defined Medium

Robust Expansion of Human Pluripotent Stem Cells: Integration of Bioprocess Design With Transcriptomic and Metabolomic Characterization

Suspension culture improves iPSC expansion and pluripotency phenotype

Controlling expansion and cardiomyogenic differentiation of human pluripotent stem cells in scalable suspension culture

Scalable expansion of iPSC and their derivatives across multiple lineages

Scalable expansion of human pluripotent stem cells under suspension culture condition with human platelet lysate supplementation

Standardized qc assays and large scale expansion of pluripotent stem cells using an automated closed system.

A fully defined static suspension culture system for large-scale human embryonic stem cell production

Laminin as a Potent Substrate for Large-Scale Expansion of Human Induced Pluripotent Stem Cells in a Closed Cell Expansion System

Developing Defined Culture Systems for Human Pluripotent Stem Cells

Non-colony type monolayer culture of human embryonic stem cells

Human embryonic stem cells: culture, differentiation, and genetic modification for regenerative medicine applications.

Modulation of Wnt and Activin/Nodal Supports Efficient Derivation, Cloning and Suspension Expansion of Human Pluripotent Stem Cells

Generation of cortical neurons through large-scale expanding neuroepithelial stem cell from human pluripotent stem cells

Long-term self-renewal of human pluripotent stem cells on human recombinant laminin-511

Human Embryonic Stem Cell Technology: Large Scale Cell Amplification and Differentiation

An Optimized Small Molecule Inhibitor Cocktail Supports Long-Term Maintenance of Human Embryonic Stem Cells.

Adaptation to Robust Monolayer Expansion Produces Human Pluripotent Stem Cells With Improved Viability

Ex Vitro Expansion of Human Placenta-Derived Mesenchymal Stem Cells in Stirred Bioreactor

Development and evaluation of a novel xeno-free culture medium for human-induced pluripotent stem cells

A novel xeno-free and feeder-cell-free system for human pluripotent stem cell culture